Five Questions with FSHD Researcher Scott Harper
MDA awarded a research grant to Scott Harper of Ohio State University to test a gene therapy for FSHD.
MDA awarded a research grant to Scott Harper of Ohio State University to test a gene therapy for FSHD.
Michael Benatar and Jonathan Katz were awarded a clinical research network grant from MDA to support their work on Clinical Procedures To Support Research (CAPTURE) project.
MDA in June announced the award of a clinical research network grant (CRNG) to Michael Benatar, M.D., Ph.D., at and Jonathan Katz, M.D.
Translarna, a new drug under development that may slow functional decline in individuals with DMD cause by nonsense mutations, will be reviewed by an Advisory Committee of the U.S. Food and Drug Administration on Sept. 28, 2017. An FDA decision on the drug is expected on or before Oct. 24, 2017.
While there is little known about what causes ALS, scientists continue seeking out answers in the hope of finding new treatments and cures.
Researchers are looking for people to participate in the Answer ALS: Individualized Initiative for ALS Discovery study.
An MDA supported project led to the discovery of a promising biomarker that could be used in developing and testing therapeutics to treat ALS.
Jie Jiang, postdoctoral fellow at the University of California – San Diego, was awarded an MDA development grant to improve understanding of ALS.
Dr. Fen-Biao Gao was awarded an MDA research grant to study the C9ORF72 repeat expansion, which is the most common genetic mutation known to cause ALS.
Dr. Eric Shoubridge of McGill University in Montreal, Québec, who was awarded an MDA research grant totaling $287,169 over three years to study a new mitochondrial gene linked to ALS.